MX2009007868A - Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona. - Google Patents
Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona.Info
- Publication number
- MX2009007868A MX2009007868A MX2009007868A MX2009007868A MX2009007868A MX 2009007868 A MX2009007868 A MX 2009007868A MX 2009007868 A MX2009007868 A MX 2009007868A MX 2009007868 A MX2009007868 A MX 2009007868A MX 2009007868 A MX2009007868 A MX 2009007868A
- Authority
- MX
- Mexico
- Prior art keywords
- hydroxy
- methylethyl
- methoxyphenyl
- ethyl
- amino
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La invención se relaciona con un proceso para la preparación de monoclorhidrato de 8-hidroxi-5-[(1R)-1-hidroxi-2[[(1R)-2-(4-metoxi fenil)-1-metiletil]amino]etil]-2(1H)-quinolinona de la fórmula (I). También se describen los intermediarios útiles en el proceso.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07001950A EP1953143A1 (en) | 2007-01-30 | 2007-01-30 | Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride |
PCT/IB2008/000134 WO2008093188A1 (en) | 2007-01-30 | 2008-01-22 | Process for the preparation of 8-hydroxy-5-[(1r)-1-hydroxy-2[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]-ethyl]-2(1h)-quinolinone monohydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009007868A true MX2009007868A (es) | 2009-07-31 |
Family
ID=38055152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009007868A MX2009007868A (es) | 2007-01-30 | 2008-01-22 | Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona. |
Country Status (14)
Country | Link |
---|---|
US (1) | US8163922B2 (es) |
EP (2) | EP1953143A1 (es) |
JP (1) | JP2010516803A (es) |
KR (1) | KR101404263B1 (es) |
CN (1) | CN101611010B (es) |
AU (1) | AU2008211655B2 (es) |
BR (1) | BRPI0806411B8 (es) |
CA (1) | CA2676849C (es) |
EA (1) | EA018170B1 (es) |
ES (1) | ES2409740T3 (es) |
HK (1) | HK1135093A1 (es) |
MX (1) | MX2009007868A (es) |
WO (1) | WO2008093188A1 (es) |
ZA (1) | ZA200905291B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR048339A1 (es) * | 2004-03-24 | 2006-04-19 | Chiesi Farma Spa | Monoclorhidrato de 8- hidroxi-5-((1r)) -1- hidroxi-2- (((1r)-2 ( 4-metoxifenil) -1- metiletil) amino ) eti l) -2 (1h) - quinolinona en form acristalina y el proceso para su preparacion |
EP2116537A1 (en) * | 2008-05-07 | 2009-11-11 | CHIESI FARMACEUTICI S.p.A. | Polymorph of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride |
EP2578570A1 (en) * | 2011-10-07 | 2013-04-10 | Almirall, S.A. | Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis. |
EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
ES2815123T3 (es) | 2014-01-09 | 2021-03-29 | Davuluri Ramamohan Rao | Proceso novedoso para la preparación de indacaterol o sus sales aceptables farmacéuticamente |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
EP1452179A1 (en) * | 2003-02-27 | 2004-09-01 | CHIESI FARMACEUTICI S.p.A. | Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid |
AR048339A1 (es) | 2004-03-24 | 2006-04-19 | Chiesi Farma Spa | Monoclorhidrato de 8- hidroxi-5-((1r)) -1- hidroxi-2- (((1r)-2 ( 4-metoxifenil) -1- metiletil) amino ) eti l) -2 (1h) - quinolinona en form acristalina y el proceso para su preparacion |
-
2007
- 2007-01-30 EP EP07001950A patent/EP1953143A1/en not_active Withdrawn
-
2008
- 2008-01-22 BR BRPI0806411A patent/BRPI0806411B8/pt not_active IP Right Cessation
- 2008-01-22 AU AU2008211655A patent/AU2008211655B2/en not_active Ceased
- 2008-01-22 CN CN2008800033686A patent/CN101611010B/zh not_active Expired - Fee Related
- 2008-01-22 EA EA200900926A patent/EA018170B1/ru not_active IP Right Cessation
- 2008-01-22 KR KR1020097014047A patent/KR101404263B1/ko active IP Right Grant
- 2008-01-22 WO PCT/IB2008/000134 patent/WO2008093188A1/en active Application Filing
- 2008-01-22 EP EP08702287A patent/EP2109603B1/en active Active
- 2008-01-22 ES ES08702287T patent/ES2409740T3/es active Active
- 2008-01-22 CA CA2676849A patent/CA2676849C/en not_active Expired - Fee Related
- 2008-01-22 MX MX2009007868A patent/MX2009007868A/es active IP Right Grant
- 2008-01-22 ZA ZA200905291A patent/ZA200905291B/xx unknown
- 2008-01-22 JP JP2009547775A patent/JP2010516803A/ja active Pending
-
2009
- 2009-07-30 US US12/512,187 patent/US8163922B2/en not_active Expired - Fee Related
-
2010
- 2010-02-12 HK HK10101634.8A patent/HK1135093A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA018170B1 (ru) | 2013-06-28 |
KR101404263B1 (ko) | 2014-06-05 |
US8163922B2 (en) | 2012-04-24 |
HK1135093A1 (es) | 2010-05-28 |
CN101611010B (zh) | 2012-03-21 |
EP2109603B1 (en) | 2013-04-03 |
CA2676849C (en) | 2015-12-15 |
EP2109603A1 (en) | 2009-10-21 |
BRPI0806411B8 (pt) | 2021-05-25 |
CN101611010A (zh) | 2009-12-23 |
BRPI0806411A2 (pt) | 2011-09-06 |
KR20090104820A (ko) | 2009-10-06 |
BRPI0806411B1 (pt) | 2020-10-13 |
EP1953143A1 (en) | 2008-08-06 |
AU2008211655A1 (en) | 2008-08-07 |
CA2676849A1 (en) | 2008-08-07 |
EA200900926A1 (ru) | 2010-02-26 |
ES2409740T3 (es) | 2013-06-27 |
AU2008211655B2 (en) | 2013-04-04 |
WO2008093188A1 (en) | 2008-08-07 |
JP2010516803A (ja) | 2010-05-20 |
US20090326231A1 (en) | 2009-12-31 |
ZA200905291B (en) | 2010-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009007868A (es) | Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona. | |
TWI370121B (en) | Process for the preparation of a 2-pyridylethylcarboxamide derivative | |
MA35452B1 (fr) | 3-pyrimidin-4-yl-oxazolidin-2-ones comme inhibiteurs d'idh mutante | |
BRPI0407904A (pt) | processo para a preparação de sal de 5-[(r)-2-(5,6-dietil-indan-2-ilaino) -1hidróxi-etil]-8-hidróxi-(1h)-quinolin-2-ona, útil como um agonista do adrenoceptor | |
MX2021013687A (es) | Nuevas formas solidas de acido (2s,3s,4s,5r,6s)-3,4,5-trihidroxi-6 -(((4ar,10ar)-7-hidroxi-1-propil-1,2,3,4,4a,5,10,10a-octahidroben zo[g]quinolin-6-il)oxi)tetrahidro-2h-piran-2-carboxilico. | |
WO2007057225A3 (en) | Process for making montelukast and intermediates therefor | |
PH12014502210A1 (en) | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one | |
MX361428B (es) | Formas polimorficas st-246 y metodos de preparacion. | |
TN2012000177A1 (fr) | Nouvelle association entre le 4-(3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide et un inhibiteur de l'acetylcholinesterase et les compositions pharmaceutiques qui la contiennent | |
WO2008059521A3 (en) | Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin | |
WO2010004578A3 (en) | Novel and improved processes for the preparation of paliperidone | |
WO2010003084A3 (en) | Phosphodiesterase 4 inhibitors | |
ES2970361T3 (es) | Sales de ácido tartárico de [2-(3-fluoro-5-metanosulfonilfenoxi)etil](propil)amina | |
MX2021010098A (es) | Un proceso para la sintesis de compuestos de diamida antranilica y compuestos intermedios de los mismos. | |
TNSN06249A1 (en) | 8-hydroxy-5-[(-hydroxy-2-[[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl] -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation | |
WO2009050734A3 (en) | An industrially feasible process for the manufacture of bisquinoline derivatives by using substantially pure n-monosubstituted piperazines | |
MD4345B1 (ro) | Procedeu de sinteză şi forme cristaline ale hidroclorurii de 4-{3-¢cis-hexahidrociclopenta¢c]pirol-2(1H)-il]propoxi}benzamidă şi a bazei libere, compoziţii farmaceutice care le conţin pentru tratamentul tulburărilor cognitive şi psiho-comportamentale | |
WO2012168213A3 (en) | Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline | |
WO2008136693A3 (en) | Process for the preparation of sodium salt of l-(((l(r)-(3-(2-(7-chloro-2- quinolinyl)-ethenyl)phenyl)-3-(2-(l-hydroxy-l- methylethyl)phenyl)propyl)sulfanyl)methyl)cyclopropaneacetic acid | |
MX2013005915A (es) | Inhibidores de kat ii. | |
HK1101398A1 (en) | Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2- methoxy-quinoline | |
HK1101326A1 (en) | Diastereoselective addition of lithiated n-methylimidazole on sulfinimines | |
WO2008146156A3 (en) | An improved process for the preparation of aripiprazole | |
AU2010277620A8 (en) | Ring-annulated dihydropyrrolo[2,l-a]isoquinolines | |
IL181317A0 (en) | Process for the preparation of 4,5-diamino shikimicacid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |